期刊文献+

自然流产患者血栓前状态的多因子发病趋势分析 被引量:3

Study on Multiple-factor Morbidity Trend of Thrombophilia of Spontaneous Abortion
下载PDF
导出
摘要 目的通过对自然流产患者血栓前状态的相关血栓标志物进行筛查,评估其发病规律及高危因子,提供有效的预防及治疗方案。方法将1300例自然流产患者按流产次数分为1次、2次、3次及以上,分别进行血栓标志物的检测,探讨其与流产次数的关系。结果抗凝血酶Ⅲ、纤溶酶原活性、交联纤维蛋白降解产物、纤维蛋白降解产物、纤溶酶原活化物抑制因子、组织型纤溶酶原激活物等对不良妊娠结局的影响差异具有统计学意义(P<0.01),随着流产次数的增加差异具有统计学(P<0.01)。蛋白C活性、蛋白S活性对不良妊娠结局的影响具有显著统计学差异(P<0.01),随着流产次数的增加2次与3次及以上经两两比较不具备统计学差异(P>0.05)。结论蛋白C活性、蛋白S活性可能是自然流产血栓前状态诊断与治疗的特征性指标或者无相关性。抗凝血酶Ⅲ、纤溶酶原活性、交联纤维蛋白降解产物、纤维蛋白降解产物、纤溶酶原活化物抑制因子、组织型纤溶酶原激活物是自然流产的影响因素,随着流产次数的增加特征性明显。 Objective To evaluate the occurrence regularity and high risk factors thrombophilia of spontaneous abortion and to provide effective precautions and treatments.Methods 1300 patients with spontaneous abortion were divided into four groups randomly according the abortion times,one,two,three and more.The thrombosis markers in these patients were detected.Results The thrombosis markers such as antithrombase Ⅲ,plasminogen activity,fibrin breakdown products,plasminogen activator inhibiting factor,tissue plasminogen activator had remarkable statistical difference to the bad pregnancy outcome (P 〈 0.01),it was also increased with abortion times (P 〈 0.01).The activity of protein C and protein S had remarkable statistical difference to the bad pregnancy outcome (P 〈 0.01).Conclusion The activity of protein C and protein S may be the characteristic markers in the diagnosis and treatment to thrombophilia of recurrent spontaneous abortion.The antithrombin Ⅲ,activity of plasminogen,fibrin degradation product,plasminogen activator inhibiting factor are the influence factors for recurrent spontaneous abortion.These markers become more evident along with the abortion times.
出处 《标记免疫分析与临床》 CAS 2014年第3期258-261,共4页 Labeled Immunoassays and Clinical Medicine
基金 首都医学科学发展基金(项目编号2005-SF-Ⅲ-102)
关键词 自然流产 血栓前状态 多因子 发病趋势 Spontaneous Abortion Thrombophilia Multiple-factor Morbidity Trend
  • 相关文献

参考文献7

  • 1Rey E, Kahn S R, David M, et al. Throm bophilic disorders and fetal loss: A meta-analysis . Lancet, 2003, 361 (9361) : 901-908.
  • 2Kutteh W H, Triplett D A. Thrombophilias and recurrent pregnancy loss. Sem in Reprod Med, 2006, 24 (1) : 54-66.
  • 3Brenner B. Thrombophilia and pregnancy loss. Semin Thromb Hemost, 2003,29 (2) : 165-170.
  • 4Zahed L F, Rayes R F, Mahfouz R A, et al. Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon. Am J Obstet Gynecol, 2006, 195 (4) : 1114-1118.
  • 5Pihusch R, Buchholz T, Lohse P, et al. Thrombophilic genemutations and recurrent spontaneous abortion. Prothrombin the risk in the first trimester. Am J Reprod Immunol,2001,46 (2) : 124-131.
  • 6Morrissey P E, Ramirez P J, Gohh R Y, et al. Management of thrombophilia in renal transplant patients [ J ]. Am J Transplant, 2002, 2 (9) : 872-876.
  • 7Raziel A, Kornberg Y, Friedler S, et al. Hypercoagulable throm bophilic defects and hyperhom ocysteinemia in patients with recurrent pregnancy loss. Am J Rep rod Immunol, 2001,45 (2) :65-71.

同被引文献45

  • 1陈晖,姜立新,雷艳爱.孕妇血栓前状态对胎儿生长受限及新生儿结局的影响[J].中国产前诊断杂志(电子版),2013,5(3):29-31. 被引量:9
  • 2黄尉国,王鸿利,张颖琪,朱立红,李耀辉,王学锋,程寅琳,邵慧珍,张鲁,葛维成.血浆D-二聚体检测及其临床应用[J].中华医学检验杂志,1995,18(2):71-74. 被引量:318
  • 3张建平,林其德,李大金,罗颂平,张清学,冯淑英,刘玉昆.复发性流产的诊断与治疗[J].现代妇产科进展,2006,15(7):481-492. 被引量:212
  • 4深静脉血栓形成的预防座谈会纪要骨科大手术后深静脉血栓形成预防的专家建议[J].中华骨科杂志;2005,25(10):636.
  • 5Brenner B. Hypercoagulability and recurrent miscarriages [J].Clin Adv Hematol Oncol,2010,8(7):467-469.
  • 6Brenner B. Thrombophilia and pregnancy loss in first in-tended pregnancy [J[ J Thromb Haemost,2005,3 (10):2176-2177.
  • 7Zahed LF,Rayes RF,Mahfouz RA,et al. Prevalence offactor V Leiden, prothrombin and methylene tetrahydrofo-late reductase mutations in women with adverse pregnancyoutcomes in Lebanon [J]. Am J Obstet Gynecol, 2006,195(4):1114-1118.
  • 8Rey E, Kahn SR, David M,et al. Thrombophilic disordersand fetal loss: a meta-analysis [J]. Lancet,2003,361 (9361):901-908.
  • 9De Stefano V,Finazzi G,Mannucci PM. Inherited throm-bophilia :pathogenesis,clinical syndromes,and manage-ment [J]. Blood, 1996,87 : 3531-3544.
  • 10Bradley LA,Palomaki GE,Bienstock J,et al. Can FactorVLeiden and prothrombin G20210A testing in womenwith recurrentpregnancy loss result in improved pregnan-cy outcomes results from atargeted evidence -based re-view [J]. Genet Med,2012,14(1) :39-50.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部